Literature DB >> 11770044

Upregulation of intraepithelial lymphocyte (IEL) function in the small intestinal mucosa in sepsis.

N C Nüssler1, B Stange, A K Nussler, U Settmacher, J M Langrehr, P Neuhaus, R A Hoffman.   

Abstract

Host defense mechanisms preventing bacterial invasion are particularly important in the gastrointestinal tract, since most gram-negative infections originate from there. Intraepithelial lymphocytes (IEL) seem to play an important role in this immune surveillance of the intestine, although their function in sepsis is not fully understood. To evaluate the characteristics of IEL in sepsis, C57BL/6 mice received a non-lethal dose of LPS and IEL were harvested at various time points thereafter. Although IEL displayed no phenotypic changes after endotoxemia, they displayed enhanced cytolytic activity and increased proliferation after LPS injection In addition, IEL from septic mice showed enhanced gamma interferon (IFN-gamma) production after LPS administration. The production of IFN-gamma may have induced the increased intestinal NOS-2 mRNA expression which was observed after endotoxemia. In conclusion, endotoxemia leads to functional activation of IEL without phenotypic changes. The activation of IEL and the subsequently increased NOS-2 expression may be important mechanisms in maintaining the mucosal barrier after sublethal LPS challenge.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770044     DOI: 10.1097/00024382-200116060-00009

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  3 in total

1.  Obstructive jaundice promotes intestinal-barrier dysfunction and bacterial translocation: experimental study.

Authors:  Hesham Abdeldayem; Enas Ghoneim; Ahmad Ahmad-El Refaei; Ashraf Abou-Gabal
Journal:  Hepatol Int       Date:  2007-09-20       Impact factor: 6.047

2.  Altered immune status of circulating T lymphocytes during sepsis: children also.

Authors:  Jean-Marc Cavaillon
Journal:  Crit Care       Date:  2014-08-14       Impact factor: 9.097

3.  Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy.

Authors:  H Xue; C J Field; M B Sawyer; L A Dieleman; V E Baracos
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.